nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Eletriptan—PTGS1—kidney cancer	0.00299	0.479	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—kidney cancer	0.0018	0.288	CrCbGaD
Naratriptan—Eletriptan—ABCB1—kidney cancer	0.00145	0.233	CrCbGaD
Naratriptan—Ill-defined disorder—Paclitaxel—kidney cancer	0.000565	0.000568	CcSEcCtD
Naratriptan—Vomiting—Everolimus—kidney cancer	0.000563	0.000566	CcSEcCtD
Naratriptan—Anaemia—Paclitaxel—kidney cancer	0.000562	0.000566	CcSEcCtD
Naratriptan—Paraesthesia—Vincristine—kidney cancer	0.000561	0.000565	CcSEcCtD
Naratriptan—Agitation—Paclitaxel—kidney cancer	0.000559	0.000563	CcSEcCtD
Naratriptan—Rash—Everolimus—kidney cancer	0.000558	0.000562	CcSEcCtD
Naratriptan—Dermatitis—Everolimus—kidney cancer	0.000557	0.000561	CcSEcCtD
Naratriptan—Headache—Vinblastine—kidney cancer	0.000557	0.00056	CcSEcCtD
Naratriptan—Purpura—Doxorubicin—kidney cancer	0.000555	0.000558	CcSEcCtD
Naratriptan—Headache—Everolimus—kidney cancer	0.000554	0.000558	CcSEcCtD
Naratriptan—Hypotension—Gemcitabine—kidney cancer	0.000554	0.000558	CcSEcCtD
Naratriptan—Body temperature increased—Dactinomycin—kidney cancer	0.000553	0.000557	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000552	0.000556	CcSEcCtD
Naratriptan—Asthenia—Sorafenib—kidney cancer	0.000551	0.000555	CcSEcCtD
Naratriptan—Malaise—Paclitaxel—kidney cancer	0.000549	0.000552	CcSEcCtD
Naratriptan—Vertigo—Paclitaxel—kidney cancer	0.000547	0.00055	CcSEcCtD
Naratriptan—Syncope—Paclitaxel—kidney cancer	0.000546	0.000549	CcSEcCtD
Naratriptan—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000545	0.000549	CcSEcCtD
Naratriptan—Hypersensitivity—Sunitinib—kidney cancer	0.000545	0.000548	CcSEcCtD
Naratriptan—Pruritus—Sorafenib—kidney cancer	0.000544	0.000547	CcSEcCtD
Naratriptan—Vomiting—Erlotinib—kidney cancer	0.000543	0.000546	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00054	0.000544	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Vincristine—kidney cancer	0.00054	0.000543	CcSEcCtD
Naratriptan—Fatigue—Vincristine—kidney cancer	0.000539	0.000542	CcSEcCtD
Naratriptan—Rash—Erlotinib—kidney cancer	0.000538	0.000542	CcSEcCtD
Naratriptan—Dermatitis—Erlotinib—kidney cancer	0.000538	0.000541	CcSEcCtD
Naratriptan—Palpitations—Paclitaxel—kidney cancer	0.000538	0.000541	CcSEcCtD
Naratriptan—Headache—Erlotinib—kidney cancer	0.000535	0.000538	CcSEcCtD
Naratriptan—Tinnitus—Capecitabine—kidney cancer	0.000535	0.000538	CcSEcCtD
Naratriptan—Loss of consciousness—Paclitaxel—kidney cancer	0.000535	0.000538	CcSEcCtD
Naratriptan—Pain—Vincristine—kidney cancer	0.000535	0.000538	CcSEcCtD
Naratriptan—Constipation—Vincristine—kidney cancer	0.000535	0.000538	CcSEcCtD
Naratriptan—Paraesthesia—Gemcitabine—kidney cancer	0.000533	0.000536	CcSEcCtD
Naratriptan—Cardiac disorder—Capecitabine—kidney cancer	0.000532	0.000536	CcSEcCtD
Naratriptan—Cough—Paclitaxel—kidney cancer	0.000531	0.000534	CcSEcCtD
Naratriptan—Asthenia—Sunitinib—kidney cancer	0.00053	0.000534	CcSEcCtD
Naratriptan—Dyspnoea—Gemcitabine—kidney cancer	0.000529	0.000532	CcSEcCtD
Naratriptan—Nausea—Vinblastine—kidney cancer	0.000528	0.000531	CcSEcCtD
Naratriptan—Somnolence—Gemcitabine—kidney cancer	0.000527	0.000531	CcSEcCtD
Naratriptan—Convulsion—Paclitaxel—kidney cancer	0.000527	0.000531	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—kidney cancer	0.000526	0.000529	CcSEcCtD
Naratriptan—Nausea—Everolimus—kidney cancer	0.000526	0.000529	CcSEcCtD
Naratriptan—Diarrhoea—Sorafenib—kidney cancer	0.000526	0.000529	CcSEcCtD
Naratriptan—Pruritus—Sunitinib—kidney cancer	0.000523	0.000526	CcSEcCtD
Naratriptan—Angiopathy—Capecitabine—kidney cancer	0.00052	0.000524	CcSEcCtD
Naratriptan—Immune system disorder—Capecitabine—kidney cancer	0.000518	0.000521	CcSEcCtD
Naratriptan—Arthralgia—Paclitaxel—kidney cancer	0.000518	0.000521	CcSEcCtD
Naratriptan—Myalgia—Paclitaxel—kidney cancer	0.000518	0.000521	CcSEcCtD
Naratriptan—Anxiety—Paclitaxel—kidney cancer	0.000516	0.000519	CcSEcCtD
Naratriptan—Hypersensitivity—Dactinomycin—kidney cancer	0.000516	0.000519	CcSEcCtD
Naratriptan—Chills—Capecitabine—kidney cancer	0.000515	0.000518	CcSEcCtD
Naratriptan—Arrhythmia—Capecitabine—kidney cancer	0.000512	0.000516	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000512	0.000515	CcSEcCtD
Naratriptan—Discomfort—Paclitaxel—kidney cancer	0.000512	0.000515	CcSEcCtD
Naratriptan—Fatigue—Gemcitabine—kidney cancer	0.000511	0.000515	CcSEcCtD
Naratriptan—Dizziness—Sorafenib—kidney cancer	0.000508	0.000511	CcSEcCtD
Naratriptan—Constipation—Gemcitabine—kidney cancer	0.000507	0.00051	CcSEcCtD
Naratriptan—Pain—Gemcitabine—kidney cancer	0.000507	0.00051	CcSEcCtD
Naratriptan—Nausea—Erlotinib—kidney cancer	0.000507	0.00051	CcSEcCtD
Naratriptan—Alopecia—Capecitabine—kidney cancer	0.000507	0.00051	CcSEcCtD
Naratriptan—Dry mouth—Paclitaxel—kidney cancer	0.000507	0.00051	CcSEcCtD
Naratriptan—Diarrhoea—Sunitinib—kidney cancer	0.000506	0.000509	CcSEcCtD
Naratriptan—Asthenia—Dactinomycin—kidney cancer	0.000502	0.000505	CcSEcCtD
Naratriptan—Confusional state—Paclitaxel—kidney cancer	0.000501	0.000504	CcSEcCtD
Naratriptan—Erythema—Capecitabine—kidney cancer	0.000499	0.000502	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—kidney cancer	0.000497	0.0005	CcSEcCtD
Naratriptan—Anaphylactic shock—Paclitaxel—kidney cancer	0.000497	0.0005	CcSEcCtD
Naratriptan—Oedema—Paclitaxel—kidney cancer	0.000497	0.0005	CcSEcCtD
Naratriptan—Body temperature increased—Vincristine—kidney cancer	0.000494	0.000497	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—kidney cancer	0.000493	0.000497	CcSEcCtD
Naratriptan—Infection—Paclitaxel—kidney cancer	0.000493	0.000496	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—kidney cancer	0.00049	0.000493	CcSEcCtD
Naratriptan—Dizziness—Sunitinib—kidney cancer	0.000489	0.000492	CcSEcCtD
Naratriptan—Feeling abnormal—Gemcitabine—kidney cancer	0.000489	0.000492	CcSEcCtD
Naratriptan—Shock—Paclitaxel—kidney cancer	0.000489	0.000492	CcSEcCtD
Naratriptan—Vomiting—Sorafenib—kidney cancer	0.000488	0.000492	CcSEcCtD
Naratriptan—Nervous system disorder—Paclitaxel—kidney cancer	0.000487	0.00049	CcSEcCtD
Naratriptan—Thrombocytopenia—Paclitaxel—kidney cancer	0.000486	0.000489	CcSEcCtD
Naratriptan—Rash—Sorafenib—kidney cancer	0.000484	0.000487	CcSEcCtD
Naratriptan—Dermatitis—Sorafenib—kidney cancer	0.000484	0.000487	CcSEcCtD
Naratriptan—Skin disorder—Paclitaxel—kidney cancer	0.000482	0.000485	CcSEcCtD
Naratriptan—Headache—Sorafenib—kidney cancer	0.000481	0.000484	CcSEcCtD
Naratriptan—Muscle spasms—Capecitabine—kidney cancer	0.00048	0.000483	CcSEcCtD
Naratriptan—Hyperhidrosis—Paclitaxel—kidney cancer	0.00048	0.000483	CcSEcCtD
Naratriptan—Diarrhoea—Dactinomycin—kidney cancer	0.000479	0.000482	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—kidney cancer	0.000473	0.000476	CcSEcCtD
Naratriptan—Vision blurred—Capecitabine—kidney cancer	0.000471	0.000474	CcSEcCtD
Naratriptan—Vomiting—Sunitinib—kidney cancer	0.00047	0.000473	CcSEcCtD
Naratriptan—Body temperature increased—Gemcitabine—kidney cancer	0.000469	0.000472	CcSEcCtD
Naratriptan—Tremor—Capecitabine—kidney cancer	0.000468	0.000471	CcSEcCtD
Naratriptan—Rash—Sunitinib—kidney cancer	0.000466	0.000469	CcSEcCtD
Naratriptan—Dermatitis—Sunitinib—kidney cancer	0.000466	0.000469	CcSEcCtD
Naratriptan—Hypotension—Paclitaxel—kidney cancer	0.000464	0.000467	CcSEcCtD
Naratriptan—Ill-defined disorder—Capecitabine—kidney cancer	0.000463	0.000466	CcSEcCtD
Naratriptan—Headache—Sunitinib—kidney cancer	0.000463	0.000466	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—kidney cancer	0.000462	0.000465	CcSEcCtD
Naratriptan—Anaemia—Capecitabine—kidney cancer	0.000462	0.000464	CcSEcCtD
Naratriptan—Hypersensitivity—Vincristine—kidney cancer	0.000461	0.000464	CcSEcCtD
Naratriptan—Nausea—Sorafenib—kidney cancer	0.000456	0.000459	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000452	0.000455	CcSEcCtD
Naratriptan—Malaise—Capecitabine—kidney cancer	0.00045	0.000453	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—kidney cancer	0.00045	0.000453	CcSEcCtD
Naratriptan—Vertigo—Capecitabine—kidney cancer	0.000449	0.000451	CcSEcCtD
Naratriptan—Asthenia—Vincristine—kidney cancer	0.000449	0.000451	CcSEcCtD
Naratriptan—Syncope—Capecitabine—kidney cancer	0.000448	0.000451	CcSEcCtD
Naratriptan—Paraesthesia—Paclitaxel—kidney cancer	0.000446	0.000449	CcSEcCtD
Naratriptan—Vomiting—Dactinomycin—kidney cancer	0.000445	0.000448	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—kidney cancer	0.000444	0.000447	CcSEcCtD
Naratriptan—Dyspnoea—Paclitaxel—kidney cancer	0.000443	0.000446	CcSEcCtD
Naratriptan—Somnolence—Paclitaxel—kidney cancer	0.000441	0.000444	CcSEcCtD
Naratriptan—Palpitations—Capecitabine—kidney cancer	0.000441	0.000444	CcSEcCtD
Naratriptan—Rash—Dactinomycin—kidney cancer	0.000441	0.000444	CcSEcCtD
Naratriptan—Nausea—Sunitinib—kidney cancer	0.000439	0.000442	CcSEcCtD
Naratriptan—Loss of consciousness—Capecitabine—kidney cancer	0.000439	0.000442	CcSEcCtD
Naratriptan—Cough—Capecitabine—kidney cancer	0.000436	0.000438	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000429	0.000431	CcSEcCtD
Naratriptan—Fatigue—Paclitaxel—kidney cancer	0.000428	0.000431	CcSEcCtD
Naratriptan—Diarrhoea—Vincristine—kidney cancer	0.000428	0.00043	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—kidney cancer	0.000427	0.000429	CcSEcCtD
Naratriptan—Asthenia—Gemcitabine—kidney cancer	0.000426	0.000428	CcSEcCtD
Naratriptan—Arthralgia—Capecitabine—kidney cancer	0.000425	0.000428	CcSEcCtD
Naratriptan—Myalgia—Capecitabine—kidney cancer	0.000425	0.000428	CcSEcCtD
Naratriptan—Pain—Paclitaxel—kidney cancer	0.000425	0.000427	CcSEcCtD
Naratriptan—Constipation—Paclitaxel—kidney cancer	0.000425	0.000427	CcSEcCtD
Naratriptan—Anxiety—Capecitabine—kidney cancer	0.000424	0.000426	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000422	0.000424	CcSEcCtD
Naratriptan—Discomfort—Capecitabine—kidney cancer	0.00042	0.000423	CcSEcCtD
Naratriptan—Pruritus—Gemcitabine—kidney cancer	0.00042	0.000422	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—kidney cancer	0.000417	0.000419	CcSEcCtD
Naratriptan—Dry mouth—Capecitabine—kidney cancer	0.000416	0.000418	CcSEcCtD
Naratriptan—Nausea—Dactinomycin—kidney cancer	0.000416	0.000418	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—kidney cancer	0.000414	0.000417	CcSEcCtD
Naratriptan—Dizziness—Vincristine—kidney cancer	0.000413	0.000416	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—kidney cancer	0.000412	0.000414	CcSEcCtD
Naratriptan—Confusional state—Capecitabine—kidney cancer	0.000411	0.000413	CcSEcCtD
Naratriptan—Feeling abnormal—Paclitaxel—kidney cancer	0.000409	0.000412	CcSEcCtD
Naratriptan—Oedema—Capecitabine—kidney cancer	0.000408	0.00041	CcSEcCtD
Naratriptan—Diarrhoea—Gemcitabine—kidney cancer	0.000406	0.000408	CcSEcCtD
Naratriptan—Infection—Capecitabine—kidney cancer	0.000405	0.000407	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000404	0.000406	CcSEcCtD
Naratriptan—Shock—Capecitabine—kidney cancer	0.000401	0.000403	CcSEcCtD
Naratriptan—Nervous system disorder—Capecitabine—kidney cancer	0.0004	0.000402	CcSEcCtD
Naratriptan—Thrombocytopenia—Capecitabine—kidney cancer	0.000399	0.000402	CcSEcCtD
Naratriptan—Vomiting—Vincristine—kidney cancer	0.000398	0.0004	CcSEcCtD
Naratriptan—Skin disorder—Capecitabine—kidney cancer	0.000396	0.000398	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—kidney cancer	0.000395	0.000397	CcSEcCtD
Naratriptan—Urticaria—Paclitaxel—kidney cancer	0.000395	0.000397	CcSEcCtD
Naratriptan—Rash—Vincristine—kidney cancer	0.000394	0.000397	CcSEcCtD
Naratriptan—Hyperhidrosis—Capecitabine—kidney cancer	0.000394	0.000396	CcSEcCtD
Naratriptan—Dermatitis—Vincristine—kidney cancer	0.000394	0.000396	CcSEcCtD
Naratriptan—Body temperature increased—Paclitaxel—kidney cancer	0.000393	0.000395	CcSEcCtD
Naratriptan—Headache—Vincristine—kidney cancer	0.000392	0.000394	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—kidney cancer	0.000386	0.000389	CcSEcCtD
Naratriptan—Hypotension—Capecitabine—kidney cancer	0.000381	0.000383	CcSEcCtD
Naratriptan—Vomiting—Gemcitabine—kidney cancer	0.000377	0.000379	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—kidney cancer	0.000376	0.000379	CcSEcCtD
Naratriptan—Rash—Gemcitabine—kidney cancer	0.000374	0.000376	CcSEcCtD
Naratriptan—Dermatitis—Gemcitabine—kidney cancer	0.000374	0.000376	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—kidney cancer	0.000372	0.000374	CcSEcCtD
Naratriptan—Headache—Gemcitabine—kidney cancer	0.000372	0.000374	CcSEcCtD
Naratriptan—Nausea—Vincristine—kidney cancer	0.000371	0.000374	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000371	0.000374	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—kidney cancer	0.00037	0.000372	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—kidney cancer	0.000368	0.00037	CcSEcCtD
Naratriptan—Paraesthesia—Capecitabine—kidney cancer	0.000366	0.000368	CcSEcCtD
Naratriptan—Hypersensitivity—Paclitaxel—kidney cancer	0.000366	0.000368	CcSEcCtD
Naratriptan—Dyspnoea—Capecitabine—kidney cancer	0.000363	0.000366	CcSEcCtD
Naratriptan—Asthenia—Paclitaxel—kidney cancer	0.000356	0.000359	CcSEcCtD
Naratriptan—Nausea—Gemcitabine—kidney cancer	0.000352	0.000355	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000352	0.000354	CcSEcCtD
Naratriptan—Fatigue—Capecitabine—kidney cancer	0.000351	0.000354	CcSEcCtD
Naratriptan—Pruritus—Paclitaxel—kidney cancer	0.000351	0.000354	CcSEcCtD
Naratriptan—Pain—Capecitabine—kidney cancer	0.000348	0.000351	CcSEcCtD
Naratriptan—Constipation—Capecitabine—kidney cancer	0.000348	0.000351	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—kidney cancer	0.000345	0.000347	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—kidney cancer	0.000343	0.000345	CcSEcCtD
Naratriptan—Diarrhoea—Paclitaxel—kidney cancer	0.00034	0.000342	CcSEcCtD
Naratriptan—Feeling abnormal—Capecitabine—kidney cancer	0.000336	0.000338	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—kidney cancer	0.000335	0.000338	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—kidney cancer	0.000334	0.000336	CcSEcCtD
Naratriptan—Chills—Doxorubicin—kidney cancer	0.000332	0.000334	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—kidney cancer	0.00033	0.000332	CcSEcCtD
Naratriptan—Dizziness—Paclitaxel—kidney cancer	0.000328	0.00033	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—kidney cancer	0.000327	0.000329	CcSEcCtD
Naratriptan—Urticaria—Capecitabine—kidney cancer	0.000324	0.000326	CcSEcCtD
Naratriptan—Body temperature increased—Capecitabine—kidney cancer	0.000322	0.000324	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—kidney cancer	0.000322	0.000324	CcSEcCtD
Naratriptan—Vomiting—Paclitaxel—kidney cancer	0.000316	0.000318	CcSEcCtD
Naratriptan—Rash—Paclitaxel—kidney cancer	0.000313	0.000315	CcSEcCtD
Naratriptan—Dermatitis—Paclitaxel—kidney cancer	0.000313	0.000315	CcSEcCtD
Naratriptan—Headache—Paclitaxel—kidney cancer	0.000311	0.000313	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—kidney cancer	0.000309	0.000311	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—kidney cancer	0.000303	0.000305	CcSEcCtD
Naratriptan—Hypersensitivity—Capecitabine—kidney cancer	0.0003	0.000302	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—kidney cancer	0.000299	0.000301	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—kidney cancer	0.000297	0.000299	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—kidney cancer	0.000296	0.000298	CcSEcCtD
Naratriptan—Nausea—Paclitaxel—kidney cancer	0.000295	0.000297	CcSEcCtD
Naratriptan—Asthenia—Capecitabine—kidney cancer	0.000292	0.000294	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—kidney cancer	0.00029	0.000292	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—kidney cancer	0.000289	0.000291	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—kidney cancer	0.000289	0.00029	CcSEcCtD
Naratriptan—Pruritus—Capecitabine—kidney cancer	0.000288	0.00029	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—kidney cancer	0.000284	0.000286	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—kidney cancer	0.000283	0.000285	CcSEcCtD
Naratriptan—Cough—Doxorubicin—kidney cancer	0.000281	0.000283	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—kidney cancer	0.000279	0.000281	CcSEcCtD
Naratriptan—Diarrhoea—Capecitabine—kidney cancer	0.000279	0.000281	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—kidney cancer	0.000274	0.000276	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—kidney cancer	0.000274	0.000276	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—kidney cancer	0.000273	0.000275	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—kidney cancer	0.000271	0.000272	CcSEcCtD
Naratriptan—Dizziness—Capecitabine—kidney cancer	0.000269	0.000271	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—kidney cancer	0.000268	0.00027	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—kidney cancer	0.000265	0.000267	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—kidney cancer	0.000263	0.000264	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—kidney cancer	0.000263	0.000264	CcSEcCtD
Naratriptan—Infection—Doxorubicin—kidney cancer	0.000261	0.000263	CcSEcCtD
Naratriptan—Vomiting—Capecitabine—kidney cancer	0.000259	0.000261	CcSEcCtD
Naratriptan—Shock—Doxorubicin—kidney cancer	0.000258	0.00026	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—kidney cancer	0.000258	0.000259	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—kidney cancer	0.000257	0.000259	CcSEcCtD
Naratriptan—Rash—Capecitabine—kidney cancer	0.000257	0.000259	CcSEcCtD
Naratriptan—Dermatitis—Capecitabine—kidney cancer	0.000257	0.000258	CcSEcCtD
Naratriptan—Headache—Capecitabine—kidney cancer	0.000255	0.000257	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—kidney cancer	0.000255	0.000257	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—kidney cancer	0.000254	0.000256	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—kidney cancer	0.000245	0.000247	CcSEcCtD
Naratriptan—Nausea—Capecitabine—kidney cancer	0.000242	0.000244	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000239	0.000241	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—kidney cancer	0.000236	0.000237	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—kidney cancer	0.000234	0.000236	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—kidney cancer	0.000234	0.000235	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000227	0.000228	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—kidney cancer	0.000226	0.000228	CcSEcCtD
Naratriptan—Pain—Doxorubicin—kidney cancer	0.000225	0.000226	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—kidney cancer	0.000225	0.000226	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—kidney cancer	0.000216	0.000218	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—kidney cancer	0.000209	0.00021	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—kidney cancer	0.000208	0.000209	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—kidney cancer	0.000194	0.000195	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—kidney cancer	0.000188	0.00019	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—kidney cancer	0.000186	0.000187	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—kidney cancer	0.00018	0.000181	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—kidney cancer	0.000174	0.000175	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—kidney cancer	0.000167	0.000168	CcSEcCtD
Naratriptan—Rash—Doxorubicin—kidney cancer	0.000166	0.000167	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—kidney cancer	0.000165	0.000167	CcSEcCtD
Naratriptan—Headache—Doxorubicin—kidney cancer	0.000165	0.000166	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—kidney cancer	0.000156	0.000157	CcSEcCtD
